Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

661 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
To have sepsis or to be septic-is the difference between these clinical conditions important?
Petersen E, Zumla A. Petersen E, et al. Among authors: zumla a. Int J Infect Dis. 2016 Jul;48:118-9. doi: 10.1016/j.ijid.2016.04.018. Epub 2016 Apr 23. Int J Infect Dis. 2016. PMID: 27117199 No abstract available.
Lung remodeling in pulmonary tuberculosis.
Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Dheda K, et al. Among authors: zumla a. J Infect Dis. 2005 Oct 1;192(7):1201-9. doi: 10.1086/444545. Epub 2005 Aug 29. J Infect Dis. 2005. PMID: 16136463 Review.
The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis.
Lala S, Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Rook GA, Keshav S, Zumla A. Lala S, et al. Among authors: zumla a. BMC Infect Dis. 2007 Aug 16;7:96. doi: 10.1186/1471-2334-7-96. BMC Infect Dis. 2007. PMID: 17705850 Free PMC article.
Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
Rook GA, Hernández-Pando R, Zumla A. Rook GA, et al. Among authors: zumla a. J Infect Dis. 2009 Mar 1;199(5):613-8. doi: 10.1086/596654. J Infect Dis. 2009. PMID: 19199549
Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods.
Green C, Huggett JF, Talbot E, Mwaba P, Reither K, Zumla AI. Green C, et al. Lancet Infect Dis. 2009 Aug;9(8):505-11. doi: 10.1016/S1473-3099(09)70149-5. Lancet Infect Dis. 2009. PMID: 19628175 Review.
Operational research and MDG tuberculosis control targets.
Zumla A, Cobelens F. Zumla A, et al. Lancet Infect Dis. 2012 Apr;12(4):262-3. doi: 10.1016/S1473-3099(12)70034-8. Epub 2012 Mar 7. Lancet Infect Dis. 2012. PMID: 22402009 No abstract available.
Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders.
Haroon A, Zumla A, Bomanji J. Haroon A, et al. Among authors: zumla a. Clin Infect Dis. 2012 May;54(9):1333-41. doi: 10.1093/cid/cis193. Epub 2012 Mar 19. Clin Infect Dis. 2012. PMID: 22431802 Review.
Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs.
Zumla A, Maeurer M. Zumla A, et al. J Infect Dis. 2012 May 15;205 Suppl 2:S335-9. doi: 10.1093/infdis/jir881. Epub 2012 Mar 22. J Infect Dis. 2012. PMID: 22448017
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Zumla A, Abubakar I, Raviglione M, Hoelscher M, Ditiu L, McHugh TD, Squire SB, Cox H, Ford N, McNerney R, Marais B, Grobusch M, Lawn SD, Migliori GB, Mwaba P, O'Grady J, Pletschette M, Ramsay A, Chakaya J, Schito M, Swaminathan S, Memish Z, Maeurer M, Atun R. Zumla A, et al. J Infect Dis. 2012 May 15;205 Suppl 2:S228-40. doi: 10.1093/infdis/jir858. Epub 2012 Apr 3. J Infect Dis. 2012. PMID: 22476720
Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. O'Grady J, et al. Among authors: zumla a. Clin Infect Dis. 2012 Nov;55(9):1171-8. doi: 10.1093/cid/cis631. Epub 2012 Jul 17. Clin Infect Dis. 2012. PMID: 22806590
661 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page